IRB Study Number 22-1407
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Endocrinology and Metabolism Institute
Description
The current study aim is to assess the bone health over time when both hyperparathyroidism and diabetes mellitus are present, as well as to see if diabetes mellitus improves after treating primary hyperparathyroidism.
Inclusion Criteria
a) Study group: patients older than 18 years old with concomitant PHPT and DM who will undergo PTX. The indications and need for surgery will be independent from the research team.
b) Control group: patients older than 18 years old with concomitant PHPT and DM who will not undergo PTX. The indications to forgo surgery will be independent from the research team.
Exclusion Criteria
a) Patients with recurrent or persistent PHPT will not be included.
b) Patients who are included but have evidence of recurrent or persistent PHPT based on six-month laboratory workup will be excluded from the final analysis (<5% expected).
c) Patients with type 1 diabetes mellitus.
d) Patients with secondary and/or tertiary hyperparathyroidism.
